The system was used for treatment.This case is reportable as a mdr due to the medical intervention of the saline infusion that was provided to the patient.Since this event is associated with the treatment, this mdr will be against the instrument.From the instrument perspective, there was no known instrument malfunction and no instrument issue was alleged by the customer.No service was requested by the customer for this adverse event.No product was returned; therefore, a device service history review was performed.The instrument has been located at the customer's site since 23-aug-2017.As part of the review, it was determined that the instrument's last service was on 01-aug-2018.During this service the system checkout procedure was successfully completed indicating that the instrument had passed all tests, met all specifications, and was operational.Trends were reviewed for complaint categories, pale, hazy, malaise, and hypotension.No trends were detected for these complaint categories.The cellex operator's manual states in section 9: warnings and cautions that "hypotension may occur during any treatment involving extracorporeal circulation.Closely monitor the patient during the entire treatment for hypotension." the operator's manual also states in section 2-4 under adverse reactions that "the side effects of photopheresis (uvadex® used with cellex® systems) were primarily related to hypotension secondary to changes in extracorporeal volume (>1%)".The assessment is based on information available at the time of the investigation.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: pallor, other: hazy, malaise, and hypotension.Mc (b)(4), (b)(4) 11/18/2018.
|
The customer called to report that a patient experienced paleness, haziness, malaise, and hypotension during an extracorporeal photopheresis (ecp) treatment procedure.The customer stated that the treatment was proceeding well with no alarms or issues.However, after 1200mls of whole blood processed the customer reported that the patient began to look pale.The customer stated that the patient complained of feeling hazy and generally not well.The customer reported that the patient's blood pressure reading at this moment was 60/30.The customer stated that they paused the treatment in order to give the patient a saline infusion and the patient stabilized.The customer reported that they then ended the treatment with blood returned to the patient.The customer reported that the patient was in stable condition.No product was returned for investigation.
|